Federal Register / Vol. 62, No. 65 / Friday, April 4, 1997 / Notices 16173

language interpretation or other

reasonable accommodations, should

contact Ms. Jackie Duley at (301) 496–

4441 in advance of the meeting.

In accordance with provisions set

forth in sec. 552b(c)(6), Title 5, U.S.C.,

and sec. 10(d) of Pub. L. 92–463, the

meeting will be closed to the public on

May 15, from approximately 1:00 p.m.

to 2:00 p.m. for the consideration of

personnel qualifications and

performance of individual investigators

and similar items, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

The Executive Secretary, Dr. Harold

M. Schoolman, Acting Director, Lister

Hill National Center for Biomedical

Communications, National Library of

Medicine, 8600 Rockville Pike,

Bethesda, Maryland 20894, telephone

(301) 496–4441, will furnish summaries

of the meeting, rosters of committee

members, and substantive program

information.

Dated: March 31, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–8588 Filed 4–3–97; 8:45 am]

BILLING CODE 4140–01–M

Division of Research Grants; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Biological and Physiological

Sciences.

Date: April 4, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4150,

Telephone Conference.

Contact Person: Dr. Marcia Litwack,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4150, Bethesda,

Maryland 20892, (301) 435–1719.

Name of SEP: Biological and Physiological

Sciences.

Date: April 10, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4148,

Telephone Conference.

Contact Person: Dr. Philip Perkins,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4148, Bethesda,

Maryland 20892, (301) 435–1718.

This notice is being published less than 15

days prior to the above meetings due to the

urgent need to meet timing limitations

imposed by the grant review and funding

cycle.

Name of SEP: Clinical Sciences.

Date: April 16, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4214,

Telephone Conference.

Contact Person: Dr. Dan McDonald,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4214, Bethesda,

Maryland 20892, (301) 435–1215.

Name of SEP: Clinical Sciences.

Date: April 18, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4138,

Telephone Conference.

Contact Person: Dr. Anthony Chung,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4138, Bethesda,

Maryland 20892, (301) 435–1213.

Name of SEP: Clinical Sciences.

Date: April 23, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4104,

Telephone Conference.

Contact Person: Dr. Priscilla Chen,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4104, Bethesda,

Maryland 20892, (301) 435–1787.

Name of SEP: Microbiological and

Immunological Sciences.

Date: April 24, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4180,

Telephone Conference.

Contact Person: Dr. Tim Henry, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 4180, Bethesda, Maryland 20892, (301)

435–1147.

Name of SEP: Biological and Physiological

Sciences.

Date: April 28, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 6178,

Telephone Conference.

Contact Person: Dr. Nancy Pearson,

Scientific Review Administrator, 6701

Rockledge Drive, Room 6178, Bethesda,

Maryland 20892, (301) 435–1047.

Name of SEP: Biological and Physiological

Sciences.

Date: April 30, 1997.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 6178,

Telephone Conference.

Contact Person: Dr. Nancy Pearson,

Scientific Review Administrator, 6701

Rockledge Drive, Room 6178, Bethesda,

Maryland 20892, (301) 435–1047.

Name of SEP: Clinical Sciences.

Date: April 30, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4106,

Telephone Conference.

Contact Person: Ms. Josephine Pelham,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4106, Bethesda,

Maryland 20892, (301) 435–1786.

Name of SEP: Biological and Physiological

Sciences.

Date: May 5, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4150,

Telephone Conference.

Contact Person: Dr. Marcia Litwack,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4150, Bethesda,

Maryland 20892, (301) 435–1719.

Purpose/Agenda: To review Small

Business Innovation Research.

Name of SEP: Microbiological and

Immunological Sciences.

Date: April 18, 1997.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4200,

Telephone Conference.

Contact Person: Dr. Gilbert Meier,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4200, Bethesda,

Maryland 20892, (301) 435–1219.

The meetings will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: March 31, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–8587 Filed 4–3–97; 8:45 am]

BILLING CODE 4140–01–M

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies, and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS

(Formerly: National Institute on Drug

Abuse, ADAMHA, HHS).

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will
16174 Federal Register / Vol. 62, No. 65 / Friday, April 4, 1997 / Notices

be identified as such at the end of the

current list of certified laboratories, and

will be omitted from the monthly listing

thereafter.

This Notice is now available on the

internet at the following website: http:/

/www.health.org

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh or Dr. Walter Vogl,

Division of Workplace Programs, Room

13A–54, 5600 Fishers Lane, Rockville,

Maryland 20857; Tel.: (301) 443–6014.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

Aegis Analytical Laboratories, Inc., 624

Grassmere Park Rd., Suite 21,

Nashville, TN 37211, 615–331–5300

Alabama Reference Laboratories, Inc.,

543 South Hull St., Montgomery, AL

36103, 800–541–4931/334–263–5745

American Medical Laboratories, Inc.,

14225 Newbrook Dr., Chantilly, VA

22021, 703–802–6900

Associated Pathologists Laboratories,

Inc., 4230 South Burnham Ave., Suite

250, Las Vegas, NV 89119–5412, 702–

733–7866/800–433–2750

Associated Regional and University

Pathologists, Inc. (ARUP), 500 Chipeta

Way, Salt Lake City, UT 84108, 801–

583–2787/800–242–2787

Baptist Medical Center—Toxicology

Laboratory, 9601 I–630, Exit 7, Little

Rock, AR 72205–7299, 501–202–2783

(formerly: Forensic Toxicology

Laboratory Baptist Medical Center)

Bayshore Clinical Laboratory, 4555 W.

Schroeder Dr., Brown Deer, WI 53223,

414–355–4444/800–877–7016

Cedars Medical Center, Department of

Pathology, 1400 Northwest 12th Ave.,

Miami, FL 33136, 305–325–5784

Centinela Hospital Airport Toxicology

Laboratory, 9601 S. Sepulveda Blvd.,

Los Angeles, CA 90045, 310–215–

6020

Clinical Reference Lab, 8433 Quivira

Rd., Lenexa, KS 66215–2802, 800–

445–6917

CompuChem Laboratories, Inc., 1904

Alexander Drive, Research Triangle

Park, NC 27709, 919–549–8263/800–

833–3984 (Formerly: CompuChem

Laboratories, Inc., A Subsidiary of

Roche Biomedical Laboratory, Roche

CompuChem Laboratories, Inc., A

Member of the Roche Group)

Cox Health Systems, Department of

Toxicology, 1423 North Jefferson

Ave., Springfield, MO 65802, 800–

876–3652/417–269–3093 (formerly:

Cox Medical Centers)

Dept. of the Navy, Navy Drug Screening

Laboratory, Great Lakes, IL, P.O. Box

88–6819, Great Lakes, IL 60088–6819,

847–688–2045/847–688–4171

Diagnostic Services Inc., dba DSI, 4048

Evans Ave., Suite 301, Fort Myers, FL

33901, 941–418–1700/800–735–5416

Doctors Laboratory, Inc., P.O. Box 2658,

2906 Julia Dr., Valdosta, GA 31604,

912–244–4468

DrugProof, Division of Dynacare/

Laboratory of Pathology, LLC, 1229

Madison St., Suite 500, Nordstrom

Medical Tower, Seattle, WA 98104,

800–898–0180/206–386–2672

(formerly: Laboratory of Pathology of

Seattle, Inc., DrugProof, Division of

Laboratory of Pathology of Seattle,

Inc.)

DrugScan, Inc., P.O. Box 2969, 1119

Mearns Rd., Warminster, PA 18974,

215–674–9310

ElSohly Laboratories, Inc., 5 Industrial

Park Dr., Oxford, MS 38655, 601–236–

2609

General Medical Laboratories, 36 South

Brooks St., Madison, WI 53715, 608–

267–6267

Harrison Laboratories, Inc., 9930 W.

Highway 80, Midland, TX 79706,

800–725–3784/915–563–3300

(formerly: Harrison & Associates

Forensic Laboratories)

Jewish Hospital of Cincinnati, Inc., 3200

Burnet Ave., Cincinnati, OH 45229,

513–569–2051

LabOne, Inc., 8915 Lenexa Dr., Overland

Park, Kansas 66214, 913–888–3927/

800–728–4064 (formerly: Center for

Laboratory Services, a Division of

LabOne, Inc.)

Laboratory Corporation of America, 888

Willow St., Reno, NV 89502, 702–

334–3400 (formerly: Sierra Nevada

Laboratories, Inc.)

Laboratory Corporation of America

Holdings, 69 First Ave., Raritan, NJ

08869, 800–437–4986 (Formerly:

Roche Biomedical Laboratories, Inc.)

Laboratory Specialists, Inc., 113 Jarrell

Dr., Belle Chasse, LA 70037, 504–

392–7961

Marshfield Laboratories, Forensic

Toxicology Laboratory, 1000 North

Oak Ave., Marshfield, WI 54449, 715–

389–3734/800–331–3734

MedExpress/National Laboratory

Center, 4022 Willow Lake Blvd.,

Memphis, TN 38118, 901–795–1515/

800–526–6339

Medical College Hospitals Toxicology

Laboratory, Department of Pathology,

3000 Arlington Ave., Toledo, OH

43614, 419–381–5213

Medlab Clinical Testing, Inc., 212

Cherry Lane, New Castle, DE 19720,

302–655–5227

MedTox Laboratories, Inc., 402 W.

County Rd. D, St. Paul, MN 55112,

800–832–3244/612–636–7466

Methodist Hospital of Indiana, Inc.,

Department of Pathology and

Laboratory Medicine, 1701 N. Senate

Blvd., Indianapolis, IN 46202, 317–

929–3587

Methodist Medical Center Toxicology

Laboratory, 221 N.E. Glen Oak Ave.,

Peoria, IL 61636, 800–752–1835/309–

671–5199

MetroLab-Legacy Laboratory Services,

235 N. Graham St., Portland, OR

97227, 503–413–4512, 800–237–7808

(x4512)

Minneapolis Veterans Affairs Medical

Center, Forensic Toxicology

Laboratory, 1 Veterans Drive,

Minneapolis, Minnesota 55417, 612–

725–2088

National Toxicology Laboratories, Inc.,

1100 California Ave., Bakersfield, CA

93304, 805–322–4250

Northwest Toxicology, Inc., 1141 E.

3900 South, Salt Lake City, UT 84124,

800–322–3361

Oregon Medical Laboratories, P.O. Box

972, 722 East 11th Ave., Eugene, OR

97440–0972, 541–687–2134

Pathology Associates Medical

Laboratories, East 11604 Indiana,

Spokane, WA 99206, 509–926–2400/

800–541–7891

PharmChem Laboratories, Inc., 1505–A

O’Brien Dr., Menlo Park, CA 94025,

415–328–6200/800–446–5177

PharmChem Laboratories, Inc., Texas

Division, 7606 Pebble Dr., Fort Worth,

TX 76118, 817–595–0294 (formerly:

Harris Medical Laboratory)

Physicians Reference Laboratory, 7800

West 110th St., Overland Park, KS

66210, 913–338–4070/800–821–3627
Federal Register / Vol. 62, No. 65 / Friday, April 4, 1997 / Notices 16175

Poisonlab, Inc., 7272 Clairemont Mesa

Blvd., San Diego, CA 92111, 619–279–

2600/800–882–7272

Premier Analytical Laboratories, 15201

I–10 East, Suite 125, Channelview, TX

77530, 713–457–3784/800–888–4063

(formerly: Drug Labs of Texas)

Presbyterian Laboratory Services, 1851

East Third Street, Charlotte, NC

28204, 800–473–6640

Quest Diagnostics Incorporated, 4770

Regent Blvd., Irving, TX 75063, 800–

526–0947/972–916–3376 (formerly:

Damon Clinical Laboratories, Damon/

MetPath, CORNING Clinical

Laboratories)

Quest Diagnostics Incorporated, 875

Greentree Rd., 4 Parkway Ctr.,

Pittsburgh, PA 15220–3610, 800–574–

2474/412–920–7733 (formerly: MedChek Laboratories, Inc., Med-Chek/

Damon, MetPath Laboratories,

CORNING Clinical Laboratories)

Quest Diagnostics Incorporated, 4444

Giddings Road, Auburn Hills, MI

48326, 810–373–9120 (formerly:

HealthCare/Preferred Laboratories,

HealthCare/MetPath, CORNING

Clinical Laboratories)

Quest Diagnostics Incorporated, 1355

Mittel Blvd., Wood Dale, IL 60191,

630–595–3888 (formerly: MetPath,

Inc., CORNING MetPath Clinical

Laboratories, CORNING Clinical

Laboratories Inc.)

Quest Diagnostics Incorporated, 2320

Schuetz Rd., St. Louis, MO 63146,

800–288–7293/314–991–1311

(formerly: Metropolitan Reference

Laboratories, Inc., CORNING Clinical

Laboratories, South Central Division)

Quest Diagnostics Incorporated, One

Malcolm Ave., Teterboro, NJ 07608,

201–393–5590 (formerly: MetPath,

Inc., CORNING MetPath Clinical

Laboratories, CORNING Clinical

Laboratory)

Quest Diagnostics Incorporated,

National Center for Forensic Science,

1901 Sulphur Spring Rd., Baltimore,

MD 21227, 410–536–1485 (formerly:

Maryland Medical Laboratory, Inc.,

National Center for Forensic Science,

CORNING National Center for

Forensic Science)

Quest Diagnostics Incorporated, 7470

Mission Valley Rd., San Diego, CA

92108–4406, 800–446–4728/619–686–

3200 (formerly: Nichols Institute,

Nichols Institute Substance Abuse

Testing (NISAT), CORNING Nichols

Institute, CORNING Clinical

Laboratories)

Scientific Testing Laboratories, Inc., 463

Southlake Blvd., Richmond, VA

23236, 804–378–9130

Scott & White Drug Testing Laboratory,

600 S. 25th St., Temple, TX 76504,

800–749–3788

S.E.D. Medical Laboratories, 500 Walter

NE, Suite 500, Albuquerque, NM

87102, 505–727–8800/800–999–LABS

SmithKline Beecham Clinical

Laboratories, 7600 Tyrone Ave., Van

Nuys, CA 91405, 818–989–2520/800–

877–2520

SmithKline Beecham Clinical

Laboratories, 801 East Dixie Ave.,

Leesburg, FL 34748, 352–787–9006,

(formerly: Doctors & Physicians

Laboratory)

SmithKline Beecham Clinical

Laboratories, 3175 Presidential Dr.,

Atlanta, GA 30340, 770–452–1590

(formerly: SmithKline Bio-Science

Laboratories)

SmithKline Beecham Clinical

Laboratories, 506 E. State Pkwy.,

Schaumburg, IL 60173, 847–447–

4379/800–447–4379 (formerly:

International Toxicology Laboratories)

SmithKline Beecham Clinical

Laboratories, 400 Egypt Rd.,

Norristown, PA 19403, 800–523–

0289/610–631–4600 (formerly:

SmithKline Bio-Science Laboratories)

SmithKline Beecham Clinical

Laboratories, 8000 Sovereign Row,

Dallas, TX 75247, 214–638–1301

(formerly: SmithKline Bio-Science

Laboratories)

South Bend Medical Foundation, Inc.,

530 N. Lafayette Blvd., South Bend,

IN 46601, 219–234–4176

Southwest Laboratories, 2727 W.

Baseline Rd., Suite 6, Tempe, AZ

85283, 602–438–8507

St. Anthony Hospital (Toxicology

Laboratory), P.O. Box 205, 1000 N.

Lee St., Oklahoma City, OK 73102,

405–272–7052

Toxicology & Drug Monitoring

Laboratory, University of Missouri

Hospital & Clinics, 2703 Clark Lane,

Suite B, Lower Level, Columbia, MO

65202, 573–882–1273

Toxicology Testing Service, Inc., 5426

N.W. 79th Ave., Miami, FL 33166,

305–593–2260

TOXWORX Laboratories, Inc., 6160

Variel Ave., Woodland Hills, CA

91367, 818–226–4373 / 800–966–

2211, (formerly: Laboratory

Specialists, Inc.; Abused Drug

Laboratories; MedTox Bio-Analytical,

a Division of MedTox Laboratories,

Inc.)

UNILAB, 18408 Oxnard St., Tarzana,

CA 91356, 800–492–0800 / 818–996–

7300 (formerly: MetWest-BPL

Toxicology Laboratory)

UTMB Pathology-Toxicology

Laboratory, University of Texas

Medical Branch, Clinical Chemistry

Division, 301 University Boulevard,

Room 5.158, Old John Sealy,

Galveston, Texas 77555–0551, 409–

772–3197.

The following laboratory withdrew

from the National Laboratory

Certification Program on March 3, 1997:

Puckett Laboratory, 4200 Mamie St.,

Hattiesburgh, MS 39402.

The Standards Council of Canada

(SCC) Laboratory Accreditation Program

for Substances Abuse (LAPSA) has been

given deemed status by the Department

of Transportation. The SCC has

accredited the following Canadian

laboratory for the conduct of forensic

urine drug testing required by

Department of Transportation

regulations: NOVAMANN (Ontario)

Inc., 5540 McAdam Rd., Mississauga,

ON, Canada L4Z 1P1, 905–890–2555.

Richard Kopanda,

Executive Officer, Substance Abuse and

Mental Health Services Administration.

[FR Doc. 97–8311 Filed 4–3–97; 8:45 am]

BILLING CODE 4160–20–P

DEPARTMENT OF HOUSING AND

URBAN DEVELOPMENT

[Docket No. FR–4200–N–49]

Notice of Proposed Information

Collection for Public Comment

AGENCY: Office of the Assistant

Secretary for Community Planning and

Development, HUD.

ACTION: Notice.

SUMMARY: The proposed information

collection requirement described below

will be submitted to the Office of

Management and Budget (OMB) for

review, as required by the Paperwork

Reduction Act. The Department is

soliciting public comments on the

subject proposal.

DATES: Comments due: June 3, 1997.

ADDRESSES: Interested persons are

invited to submit comments regarding

this proposal. Comments should refer to

the proposal by name and/or OMB

Control Number and should be sent to:

Reports Liaison Officer, Shelia E. Jones,

Department of Housing and Urban

Development, 451—7th Street, SW,

Room 7230, Washington, DC 20410.

FOR FURTHER INFORMATION CONTACT:

Tony Johnston, Deputy Director,

Financial Management Division, Office

of Block Grant Assistance, Room 7180,

Department of Housing and Urban

Development, 451 Seventh Street, SW,

Washington, DC 20410, telephone (202)

708–1871. Hearing- or speech-impaired

individuals may access this number via

TTY by calling the Federal Information

Relay Service at 1–800–877–8399. Fax

inquiries may be sent to Mr. Johnston at

(202) 708–1798. (Other than the ‘‘800’’